866-997-4948(US-Canada Toll Free)

Induced Pluripotent Stem Cells: Global Markets

Published By :

BCC Research

Published Date : Jun 2017

Category :

Biotechnology

No. of Pages : 139 Pages

Report Highlights

The global market for induced pluripotent stem cells (iPSCs) was estimated to total $853 million in 2012, and close to $1.2 billion in 2013, averaging 40% growth. The market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018.

Report Includes

  • An overview of the global market for induced pluripotent stem cells.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Information on induced pluripotent stem cell research products, defined as all research tools including but not limited to: induced pluripotent stem cells and various differentiated cells derived from induced pluripotent stem cells, various related assays and kits, culture media and medium components such as serum, growth factors and inhibitors, antibodies, enzymes, and many others that can be applied for the specific purpose of executing induced pluripotent stem cell research.
  • Discussion of¬†important manufacturers, technologies, and factors influencing market demand such as the driving forces and limiting factors of induced pluripotent stem cell market growth.¬†

Report Scope

This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells, and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by analyzing the funding, patent publications and sales trends of major players in the field.

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Overview
Chapter 4 Induced Pluripotent Stem Cell Applications
Chapter 5 Induced Pluripotent Stem Cell Market Segmentation and Forecast
Chapter 6 Induced Pluripotent Stem Cell Research Application Market
Chapter 7 Drug Discovery and Development Market
Chapter 8 Induced Pluripotent Stem Cell Contract Service Market
Chapter 9 Induced Pluripotent Stem Cell Clinical Application Market
Chapter 10 Research Market Trend Analysis
Chapter 11 Clinical Application Market Trend Analysis
Chapter 12 Company Profiles
Chapter 13 Conclusions
Key Drivers for Market Growth
Introduction
History and Current State
Evolution of Induced Pluripotent Stem Cell Research
Induced Pluripotent Stem Cell Advantages and Disadvantages
Technology Overview
Advantages
Disadvantages
Induced Pluripotent Stem Cell Generation
Induced Pluripotent Stem Cell Differentiation
Retrovirus and Lentivirus
Adenovirus
Sendai Virus
Episomal Plasmids
PiggyBac
Minicircle Vectors
Synthetic mRNA
Protein
Small-Molecular Chemicals
Cardiomyocytes
Hepatocytes
Neurons
Endothelia Cells
Academic Research
Pharmaco-Toxicological Screening
Drug Discovery and Development
Disease Modeling
Tissue Engineering
Cell Therapy
Induced Pluripotent Stem Cell Market Overview
Application-Based Market Overview
U.S. Induced Pluripotent Stem Cell Product Market
Induced Pluripotent Stem Cell-Derived Tissue Cell Market
Induced Pluripotent Stem Cell and Derivative Cell Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Induced Pluripotent Stem Cell-Derived Cell Markets by Application
Induced Pluripotent Stem Cell Market by Product Function
Research Market vs. Clinical Market
Application-Based Markets for Induced Pluripotent Stem Cell-Derived Cells
Induced Pluripotent Stem Cells and Their Derived Cells Market by Species
Induced Pluripotent Stem Cell Culture Markets
Global Market
Regional Markets
Market for Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells
Market for Human Hepatocytes Derived from Induced Pluripotent Stem Cells
Market for Human Endothelia Cells Derived from Induced Pluripotent Stem Cells
Regional Markets
Market for Human Neural Cells Derived from Induced Pluripotent Stem Cells
Regional Markets
Global Market
Regional Markets
Global Market
Regional Markets
Global Market
Regional Markets
Global Market
Global Market
Induced Pluripotent Stem Cell Research Product Types
Major Players
Market Shares and Projections
Major Commercial Entities
Major Non-Commercial Organizations
Top Institutions Performing Induced Pluripotent Stem Cell Research
Induced Pluripotent Stem Cell Core Facilities
Product Types
Major Players
Market Shares and Projections
Induced Pluripotent Stem Cell Contract Service Types
Major Players
Market Shares and Projections
Product Types
Regulations
Market Projection
Grant Analysis
Patent Analysis
Scientific Publication Analysis
Driving Forces
Clinical Trials
Driving Forces
Limiting Factors
Technologies
Regulations
Market Acceptance
Clinical Efficiency
ABM (APPLIED BIOLOGICAL MATERIALS INC.)
ADDGENE
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
ALSTEM LLC
APPLIED STEMCELL INC.
ATCC
AXIOGENESIS AG
AXOL BIOSCIENCEE
BIO-TECHNE
BLUEROCK THERAPEUTICS
BRISTOL-MYERS SQUIBB (IPIERIAN)
CELL SIGNALING TECHNOLOGY
CELLULAR DYNAMICS INTERNATIONAL, A FUJIFILM COMPANY
CORNING LIFE SCIENCES
CREATIVE BIOARRAY
EMD MILLIPORE
FATE THERAPEUTICS
GENECOPOEIA
GENTARGET INC.
ID PHARMA CO. LTD.
INVIVOGEN
LONZA GROUP LTD.
MELLO BIOTECHNOLOGY INC.
MTI-GLOBALSTEM
NEWCELLS BIOTECH
OPSIS THERAPEUTICS
ORIG3N INC.
PEPROTECH
PLASTICELL LTD.
PLURIOMICS B.V.
PRIMORIGEN BIOSCIENCES
PROMEGA CORP.
PROMOCELL GMBH
QIAGEN N.V.
REPROCELL INC.
ROSLIN CELL SCIENCES
SCIENCELL RESEARCH LABORATORIES
SIGMA-ALDRICH, A PART OF MILLIPORESIGMA
STEMCELL TECHNOLOGIES
STEM CELL THERANOSTICS INC.
STEMGENT INC., A REPROCELL GROUP COMPANY
SYSTEM BIOSCIENCES INC.
TAKARA BIO USA INC. (CLONTECH LABORATORIES)
THERMO FISHER SCIENTIFIC
VIACYTE INC.

List of Table

Summary Table : Global Induced Pluripotent Stem Cell Market, by Region, Through 2021
Table 1 : U.S. Induced Pluripotent Stem Cell Product Market, by State, Through 2021
Table 2 : Global Market for Methods for Generating Induced Pluripotent Stem Cells (Integrated and Non-Integrated), Through 2021
Table 3 : Global Market for Methods for Generating Induced Pluripotent Stem Cells, Through 2021
Table 4 : Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2021
Table 5 : U.S. Induced Pluripotent Stem Cell Product Market, by Application, Through 2021
Table 6 : Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2021
Table 7 : Global Market for Induced Pluripotent Stem Cell Derived Cells, by Species, Through 2021
Table 8 : Major Commercial Induced Pluripotent Stem Cell Product Suppliers, March 31, 2017
Table 9 : Major Commercial Induced Pluripotent Stem Cell Product Manufacturers March 31, 2017
Table 10 : Global Induced Pluripotent Stem Cell-Derived Cell Market, by Application, Through 2021
Table 11 : Global Market for Induced Pluripotent Stem Cell-Related Products by Product Function, Through 2021
Table 12 : U.S. Market for Induced Pluripotent Stem Cell-Related Products by Product Function, Through 2021
Table 13 : Global Markets for Induced Pluripotent Stem Cells, by Research and Clinical Use, Through 2021
Table 14 : Global Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021
Table 15 : U.S. Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021
Table 16 : European Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021
Table 17 : Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, Through 2021
Table 18 : Global Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021
Table 19 : U.S. Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021
Table 20 : European Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021
Table 21 : Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, Through 2021
Table 22 : Global Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021
Table 23 : U.S. Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021
Table 24 : European Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021
Table 25 : Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, Through 2021
Table 26 : Global Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021
Table 27 : U.S. Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021
Table 28 : European Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021
Table 29 : Asia-Pacific Market for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, Through 2021
Table 30 : Global Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021
Table 31 : U.S. Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021
Table 32 : European Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021
Table 33 : Asia-Pacific Market for Induced Pluripotent Stem Cells and Derivative Cells, by Species, Through 2021
Table 34 : Global Market for Cell Culture Products for Induced Pluripotent Stem Cells and Derived Cells, by Region, Through 2021
Table 35 : Global Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2021
Table 36 : U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2021
Table 37 : Global Market for Induced Pluripotent Stem Cell-Derived Cell Products for Research, by Cell Type, Through 2021
Table 38 : Global Market for Induced Pluripotent Stem Cell Research, by Region, Through 2021
Table 39 : Major University and Institute Induced Pluripotent Stem Cell Core Facilities, by Location
Table 40 : Global Market for Induced Pluripotent Stem Cell-Derived Cell Products for Drug Development and Toxicity Testing, by Cell Type, Through2021
Table 41 : Global Market for Induced Pluripotent Stem Cell Drug Development and Toxicity Testing, by Region, Through 2021
Table 42 : Major Companies Providing Induced Pluripotent Stem Cell Contract Services, 2016
Table 43 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2021
Table 44 : Global Market for Induced Pluripotent Stem Cell Products for Regenerative Medicine, by Cell Type, Through 2021
Table 45 : Induced Pluripotent Stem Cell Clinical Global Markets (Including Patient-Specific Induced Pluripotent Stem Cell Banking), by Region, Through 2021
Table 46 : Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-2016
Table 47 : National Institutes of Health Induced Pluripotent Stem Cell Research Funding, FY 2006-2016
Table 48 : California Institute of Regenerative Medicine Induced Pluripotent Stem Cell Funding, Through January 2017
Table 49 : Induced Pluripotent Stem Cell Patents Issued, by the U.S. Patent and Trademark Office, 2011 to December 2016
Table 50 : U.S. Patent and Trademark Office-Issued Patents, by Region, 2011 to December 2016
Table 51 : Distribution of Induced Pluripotent Stem Cell Patents and Patent Applications with WIPO, by Filing Office or Country, 2011 to October 2016
Table 52 : Main Inventors of Global Induced Pluripotent Stem Cell Patents or Patent Applications, 2011 to October 2016
Table 53 : Main Applicants of Global Induced Pluripotent Stem Cell Patent Applications, 2011 to October 2016
Table 54 : World Intellectual Property Office Induced Pluripotent Stem Cell Patent Publications, by Year, 2007-2016
Table 55 : U.S. Patent and Trademark Office Induced Pluripotent Stem Cell Patent Applications, 2009-2016
Table 56 : Global Distribution of Induced Pluripotent Stem Cell Patents and Patent Applications with USPTO, by Country, Through 2016
Table 57 : U.S. Induced Pluripotent Stem Cell Patents and Patent Applications by State, Through 2016
Table 58 : World Intellectual Property Organization Induced Pluripotent Stem Cell Patent Publications, by Category, Through 2016
Table 59 : Induced Pluripotent Stem Cell Publications, 2006-2016

List of Chart

Summary Figure : Global Induced Pluripotent Stem Cell Market, by Region, 2015-2021
Figure 1 : Global Induced Pluripotent Stem Cell Product Market Shares, by Region, 2021
Figure 2 : U.S. Induced Pluripotent Stem Cell Product Market Shares, by State, 2021
Figure 3 : Global Market Shares for Generating Induced Pluripotent Stem Cells, by Methods, 2021
Figure 4 : Global Market Shares for Generating Induced Pluripotent Stem Cells, by Methods, 2021
Figure 5 : Global Market Shares for Induced Pluripotent Stem Cell Products, by Application, 2021
Figure 6 : U.S. Market Shares for Induced Pluripotent Stem Cell Products, by Application, 2021
Figure 7 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2021
Figure 8 : Major Commercial Induced Pluripotent Stem Cell Suppliers, by Country, 2016
Figure 9 : Major U.S. Commercial Induced Pluripotent Stem Cell Product Suppliers, by State, 2016
Figure 10 : Major Commercial Induced Pluripotent Stem Cell Product Manufacturers, by Country, 2016
Figure 11 : Major U.S. Commercial Induced Pluripotent Stem Cell Product Manufacturers, by State, 2016
Figure 12 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Cells, by Application, 2021
Figure 13 : Global Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021
Figure 14 : U.S. Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021
Figure 15 : Global Market Shares for Induced Pluripotent Stem Cells, by Research and Clinical Use, 2021
Figure 16 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021
Figure 17 : U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021
Figure 18 : European Market for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021
Figure 19 : Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes, by Application, 2021
Figure 20 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021
Figure 21 : U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021
Figure 22 : European Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021
Figure 23 : Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Hepatocytes, by Application, 2021
Figure 24 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021
Figure 25 : U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021
Figure 26 : European Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021
Figure 27 : Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Endothelia Cells, by Application, 2021
Figure 28 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021
Figure 29 : U.S. Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021
Figure 30 : European Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021
Figure 31 : Asia-Pacific Market Shares for Induced Pluripotent Stem Cell-Derived Human Neural Cells, by Application, 2021
Figure 32 : Global Market Shares for Induced Pluripotent Stem Cells and Derivative Cells, by Species, 2021
Figure 33 : Global Market Shares for Induced Pluripotent Stem Cell Culture Products, by Region, 2021
Figure 34 : Global Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021
Figure 35 : U.S. Market Shares for Induced Pluripotent Stem Cells, by Product Function, 2021
Figure 36 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Cell Research, by Cell Type, 2021
Figure 37 : Global Market Shares for Induced Pluripotent Stem Cell Research, by Region, 2021
Figure 38 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Cells Drug Development and Toxicity Testing, by Cell Type, 2021
Figure 39 : Global Market Shares for Induced Pluripotent Stem Cell Drug Development and Toxicity Testing, by Region, 2021
Figure 40 : Global Market Shares for Induced Pluripotent Stem Cell Contract Services, by Region, 2021
Figure 41 : Global Market Shares for Induced Pluripotent Stem Cell-Derived Regenerative Medicine, by Cell Type, 2021
Figure 42 : Induced Pluripotent Stem Cell Clinical Global Market Shares, by Region, 2021
Figure 43 : Major Governmental Induced Pluripotent Stem Cell Research Funding, by Region, 2006-2016
Figure 44 : National Institutes of Health Induced Pluripotent Stem Cell Research Funding, 2006-2016
Figure 45 : World Intellectual Property Office Induced Pluripotent Stem Cell Patent Applications, 2007-2016
Figure 46 : U.S. Patent and Trademark Office Induced Pluripotent Stem Cell Patent Applications, 2009-2016
Figure 47 : Induced Pluripotent Stem Cell Research Publications, 2006-2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *